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Abstract
In the field of regenerative medicine, biomaterials play a crucial role since 
they may serve as a support (scaffold) to promote cell growth and differentia-
tion in order to promote the healing of tissue lesion. The aim of this chapter 
will be to analyze the properties of more recent biomaterials suitable for tissue 
engineering strategies, to end to define better and innovative materials for scaf-
fold production. To this purpose, we will analyze the main materials (natural 
and synthetic) and their characteristics, such as biocompatibility, bioactiv-
ity, and biodegradation, and it will be discussed how their chemical-physical 
properties (surface morphology, porosity, stiffness, and mechanical strength) 
could affect the interaction with cells and living system. Moreover, the chapter 
will be focused on methods of extraction or production of biomaterial suitable 
for scaffolds.
Keywords: biomaterial, scaffold, polymers, biocompatibility, surface, porosity, 
synthesizing
1. Introduction
The promising field of tissue engineering (TE) purposes to restore damaged 
tissues by combining cells with biomimetic materials able to act as templates for 
tissue regeneration and to drive new tissue growth. The term “tissue engineering” 
was formally conceived at a National Science Foundation workshop in 1988 as “the 
application of principles and methods of engineering and life sciences toward the 
fundamental understanding of structure-function relationships in normal and 
pathological mammalian tissues and the development of biological substitutes to 
restore, maintain or improve tissue function” [1].
According to the definition of Langer and Vacanti, tissue engineering is “an 
interdisciplinary field of research that applies the principles of engineering and the life 
science toward the development of biological substitutes that restore, maintain or improve 
tissue function” [2].
The tissue engineering is a highly multidisciplinary field that associates several 
areas including clinical medicine, mechanical engineering, materials science, genet-
ics, and related disciplines to both engineering and the life sciences. This field is 
based principally on the use of biomimetic materials (3D scaffolds) that provide not 
only a suitable environment for the new developing tissue but also offers a structure 
for cell adhesion, proliferation, and extracellular matrix (ECM) deposition until 
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new tissue is totally restored [3]. Furthermore, the scaffolds are often combined 
with cells and signaling molecules or growth factors representing the key elements 
of tissue engineering.
2. Biomaterials for tissue engineering
The first definition of biomaterial was developed in the 1980s, during the 
Consensus Development Conference (Chester, UK, 1982) in which the biomateri-
als were defined as “any substance, other than a drug, or a combination of substances, 
synthetic or natural in origin, which can be used for any period of time, as a whole or 
as a part of a system, which treats, augments or replaces any tissue, organ or function of 
the body” [4]. Since ancient times, men searched in nature animal or plant-derived 
materials able to heal wounds, maintain, or restore body functions. In fact, the 
ancient Egyptians and Romans used vegetable fibers to sew skin lesions, and they 
were able to model wooden limb prostheses. Later, the industrial revolution allowed 
the development of a series of synthetic biomaterials (first metallics and then 
polymerics) with characteristics more and more suitable for the development of 
medical devices.
More recently, natural and synthetic biomaterials have become one of 
the important elements for regenerative medicine and tissue engineering 
strategies.
Nowadays, several types of scaffolds have been produced with a multiplicity of 
manufacture systems but the main challenge for tissue engineering is represented 
from the choice of appropriate materials for the scaffold production. To this aim, 
different types of biomaterials have been currently used, such as, natural or syn-
thetic polymers, ceramics, metals, composites, and hydrogels. Furthermore, it is 
important when planning or determining the suitability of a scaffold to evaluate 
that it fulfills the following key requirements: (i) biocompatibility, (ii) bioactivity, 
and (iii) biodegradability.
The main requirement of the scaffold for tissue engineering is its biocompat-
ibility or capability to promote cellular adhesion, proliferation, and migration 
onto the surface and eventually through the scaffold in vitro and in vivo. Moreover, 
after implantation, it must integrate into the host tissue without eliciting immune 
response in order to avoid an important inflammatory reaction that might decline 
healing or induce rejection [5].
The bioactivity represents the ability of a biomaterial to interact with surround-
ing tissue ensuring cell adhesion, proliferation, and differentiation [6]. Generally, 
biomaterials with chemical composition comparable to the host tissue have a higher 
bioactivity and can promote cellular recognition evoking specific cellular response 
to support tissue growth. To this aim, it is possible to modify the surface of the 
biomaterial by adding extracellular matrix macromolecules, including collagen, 
fibronectin, and laminin, to produce a biomimetic environment equivalent to the 
native tissue able to modulate cellular behavior and response [7].
On other essential property of scaffold for tissue engineering is the biodegrad-
ability. The biomimetic scaffolds are not permanent implants but they must be 
biodegradable to allow cells to produce their own extracellular matrix. Further, the 
by-products of this degradation must also be nontoxic and easily eliminable from 
the body without interfering with other tissues [8]. On the other hand, it is critically 
important to also know the in vivo degradation kinetics of a biomaterial to avoid an 
excessively rapid or slow elimination. In the first case, the scaffold could not satisfy 
its function of support for cells, while in the second one, it could cause necrosis or 
inflammation [9].
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3.  Scaffold design: the importance of structural and mechanical 
properties
The scaffold for tissue engineering must possess structural and mechanical 
characteristics appropriate to the anatomical site in which it must be implanted and, 
moreover, must be strong enough to allow its surgical manipulation during implan-
tation. The structural features include macro- and micro-structural properties. 
The macro-structural properties refer to a temporary 3D architecture, of critical 
importance, which mimic the ECM and allows cell to maintain their native differen-
tiated phenotypes; while, the micro-structural properties refer to scaffold porosity, 
pore shape, pore size, and interconnectivity. The mechanical properties include 
mechanical strength and stiffness.
3.1 Structural properties
Scaffold micro and macro architecture critically influences cell survive and 
surface adhesion, but also cellular proliferation, differentiation, vascularization, 
and specific gene expression [10].
If on the one hand, a scaffold may be strong enough to support the physiological 
load of the body and to allow surgical handling during implantation, on the other 
hand, it is important to obtain a porous structure to avoid cellular colonization. It is 
clear that a balance between mechanical strength and high porosity is a significant 
challenge in scaffold production.
3.1.1 Pore interconnection, porosity, and pore size
Pore interconnection, porosity, and pore size represent very important param-
eters for the scaffold production. All three features allow cellular penetration, 
vascularization, adequate diffusion of nutrients and oxygen to cells within the 
construct, and neo-formed extracellular matrix ensuring cell viability [5, 11].
In particular, pore size is a key element for the scaffold efficiency. In fact, the 
pores must be large enough to allow cells to penetrate and migrate within the 
scaffold structure, but also small enough to allow the binding of a critical number 
of cells at the same. Pores can be classified into micropores (0.1–2 nm), mesopores 
(2–50 nm), and macropores (>50 nm) according to their dimension. All the scaf-
folds used for tissue engineering may have a macroporous structure with a specific 
pore size as a function of the type of host tissue. In particular, a pore size of 20 
micron is required for hepatocyte and fibroblast growth, while the dimension is 
around 20–150 micron for soft tissue healing. For bone tissue engineering, research-
ers propose a pore size range between 200 and 400 micron.
The most common techniques used to obtain a porous structure are gas foaming, 
salt leaching, phase separation, sintering, and freeze-drying.
3.2 Mechanical properties
The scaffold for tissue engineering must have adequate mechanical integrity, so 
that it can offer support from the time of implantation until the remodeling process 
is fully completed.
3.2.1 Mechanical strength and stiffness
The mechanical strength depends on the bonding forces that hold together 
the atoms in scaffold architecture. It is an important parameter to avoid the 
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solid structure deformation due to cellular loading on the scaffold or caused by 
scaffold handling.
Another important feature of the scaffold surface is the stiffness that is mea-
sured by Young’s modulus. Cells respond to scaffold stiffness via different mecha-
nisms such as activation of ion channels or protein unfolding, and by this way, 
stiffness affects cell proliferation and differentiation. Hadjipanayi et al. demon-
strated that the increasing of free-floating collagen matrix stiffness led to a higher 
proliferation rate for human dermal fibroblasts [12].
4. Biomaterials for scaffold production
Biomaterials for tissue engineering have a considerable importance for the 
success of a tissue replacement or regeneration. In addition to interacting with the 
implant site, they have the ability to influence biological processes that are impor-
tant for tissue regeneration.
Different kinds of biomaterials have been used for scaffold production such as 
ceramics and polymers, naturals and synthetics, metals, composites, and hydrogels.
4.1 Ceramics
For several decades, ceramic biomaterials have been used to reconstruct dam-
aged body parts and for skeletal repair.
Ceramic biomaterials are inorganic compounds of natural or synthetic origin, 
which may contain metallic and nonmetallic elements. These biomaterials are 
generally made of polycrystalline solids, rarely of monocrystals and sometimes have 
an amorphous structure. Generally, their mechanical properties, including hard 
surface, high mechanical stiffness, low elasticity, low thermal expansion, chemical-
physic refractoriness, depend on the way they are produced or extracted, but their 
properties can also depend on the composition and particle size of the starting 
powders.
Ceramic scaffolds are commonly used for bone regeneration practices because 
they are highly biocompatible, rarely evoke an immune response, and hardly cause 
the formation of fibrous tissue around the scaffold; instead they are osteoinductive, 
considering their high ability to recruit cells from the biological environment and 
promote osteogenic differentiation. Although the ceramics present these advan-
tages, their use in tissue engineering applications is limited due to their fragility and 
slow degradation [1, 13, 14].
On the basis of their main features, they can be distinguished into three catego-
ries: (a) bio-inert ceramics: completely inert to biological environment; (b) resorb-
able materials: subjects to in vivo degradation for phagocytosis or dissolution of 
the material in biological fluids; and (c) bioactive ceramics: able to form chemical 
bound with the cell surface [15].
The most common ceramic biomaterials used for tissue regeneration are:  
(1) CaP, including hydroxyapatite (HA) (Ca10[PO4]6[OH]2), beta-tricalcium phos-
phate (BTF) (Ca3[PO4]2), biphasic calcium phosphate (mixture of hydroxyapatite 
and beta-tricalcium phosphate), (2) bioglass, (3) alumina (Al2O3), and (4) zirconia 
oxide (ZrO2).
CaP biomaterials are often selected for bone graft since they mimic bone tissue 
composition. One of the first used ceramic biomaterials for skeletal repair was BTF 
in 1920 by Albee and Morrinson [16].
HA may be natural or synthetic. Natural HA derives from particular species 
of coral or bovine bone and can contain traces of other elements such as Mg, Na, 
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CO3, and F. Synthetic HA is prepared by sintering in dense or macroporous form as 
granules or blocks [17]. Ray and Ward, first, showed the high biocompatibility and 
biomimicry of synthetic HA in their study in which they used this material for bone 
tissue engineering application in the long bones and iliac wings of dogs [18]. Later, 
numerous other studies on HA have been carried out. Calabrese et al. in their stud-
ies tested a composite bi-layer type-1 collagen-HA/Mg scaffold for osteochondral 
regeneration, both in vitro and in vivo. They showed that the combination of this 
scaffold with mesenchymal stem cells (MSC) derived from adipose tissue (hAD-
SCs) in the presence of specific differentiation conditions induce osteochondro 
differentiation both in vitro and in vivo [19–23].
Bioglass is composed by 45 wt% SiO2, 24.5 wt% CaO, 24.5 wt% Na2O, and 
6.0 wt% P2O5. The first one (45S5 Bioglass) has been developed by Hench, which 
used it for biomedical applications in vitro and in vivo [24].
Bioglass materials can be synthesized through different methods such as poly-
mer foam replication, thermal bonding of particles or fibers, and sol-gel process-
ing. Similarly to HA, it is suitable for bone graft due to the high ratio of calcium to 
phosphorus promoting the formation of apatite crystals on its surface after grafting. 
Bioglass materials offer high osteoinductivity, control of rate of degradation, and 
excellent bioactivity even if they can present poor mechanical properties such as 
low strength and toughness [25, 26].
Alumina (Al2O3) is a ceramic biomaterial with a crystalline structure. Generally, 
a low porosity and reduced grain size increase its mechanical strength. Like other 
ceramic materials, alumina is fragile but it has good tribological properties such as 
resistance to wear.
Zirconia is characterized by a polymorphic structure and offer has a hard 
surface, a low thermal conductivity, and a high coefficient of thermal expansion. 
Its excellent biocompatibility and high breaking load make it a good candidate for 
prosthesis and bone grafting.
4.2 Polymers
Various biological polymers such as collagen, alginate, proteoglycans, chitin, 
and chitosan have been used to produce scaffolds. They are biocompatible and 
bioactive promoting cellular adhesion and growth on their surface. However, they 
often show poor mechanical properties and fast biodegradability, which limit 
their use.
Collagen and its derivatives are good candidates for osteochondral regeneration 
but also tendon and ligament reconstruction since the extracellular matrix of these 
tissues is mostly made of type-1 collagen fibers [27–29].
Collagen scaffolds are highly bioactive ensuring excellent cellular adhesion to 
their surface. However, since they have low resistance to mechanical stress often are 
coupled with other materials, which improve their mechanical properties.
Several studies have been focused on the use of collagen scaffolds for tissue 
engineering strategies. Aravamudhan et al., for example, reported the fabrica-
tion and characterization of cellulose and collagen-based micro-nanostructured 
scaffolds exhibiting mechanical features similar to those of trabecular bone that 
promoted good adhesion of human osteoblasts to their surface. Moreover, they 
underwent a progressive calcium deposition process compared to control polyester 
micro-nanostructured scaffolds [30].
In another study, Schneider et al. developed a collagen I/III hydrogel scaffold 
and used it to seed hMSC isolated from bone marrow of femoral head spongiosa 
and from umbilical cord. When stimulated with osteogenic induction medium, 
both cell types showed comparable osteogenic gene expression, migration, and 
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scaffold colonization [31]. Collagen scaffolds may also be used to deliver osteogenic 
differentiation factors as demonstrated by Lu H. et al, who immobilized BMP4 in a 
collagen-PLGA hybrid scaffold to promote osteogenesis [32].
Polysaccharides such as chitin, chitosan, and alginate are suitable for both hard 
and soft tissue regeneration. In particular, chitosan scaffolds can be manufactured 
by freeze-drying techniques, which allow obtaining a porous scaffold with high 
pore interconnectivity. Chitosan ensures good cellular adhesion and thank to its 
positive charges can interact with glycosaminoglycans and proteoglycans present in 
living tissues. Costa-Pinto et al. cultured human bone marrow MSC on melt-based 
porous chitosan scaffolds using an osteogenic differentiation medium. They found 
an increase of cell viability and ALP activity after 21 days. They also investigated the 
capacity of the cell seeded scaffold to repair a cranial defect in mouse, and 8 weeks 
after implantation bone formation in the scaffold was analyzed using Bone μCT 
[33]. Chitosan may also be used as an injectable biomaterial as demonstrated by Bi 
et al., who produced a composite scaffold of tricalcium phosphate (TCP), chitosan, 
and platelet rich plasma (PRP). MSC seeded on injectable biomaterial was used 
in vivo to test its capacity to repair bone fracture in goat femora [34].
Synthetic polymers are high molecular weight compounds composed of a series 
of monomeric units. On the basis of their structure, they can be linear, branched, 
or cross-linked. Considering their thermo-mechanical properties, they are thermo-
plastic or thermosetting. Polymeric materials can be produced in the form of fibers, 
films, bars, and viscous liquids, and they offer the important advantage to modulate 
their mechanical properties and biodegradation by varying synthesis process and 
reactants used. However, they could have low biocompatibility and mechanical 
strength and show in vivo toxicity due to the release of ions and other residual 
particles of polymerization.
Among the different synthetic polymers, the most suitable for scaffold produc-
tion is the bio-erodible. These kinds of polymers undergo surface degradation with 
production of nontoxic low molecular weight compounds.
Numerous synthetic polymers have already been used such as: polystyrene, 
thermoplastic aromatic polymer with a linear structure; poly-l-lactic acid (PLA), 
hydrophobic polymer with slow degradation rate due to microorganisms; poly-
glycolic acid (PGA), hydrophilic polymer with good mechanical properties and fast 
degradation; poly-dl-lactic-co-glycolic acid (PLGA), biocompatible copolymers 
with fast degradation rate; and polycaprolactone (PCL), highly hydrophobic 
polymer with good permeability.
In particular, PGA and PLA and their copolymers are natural polyesters nor-
mally present in the organism and therefore well tolerated. They have been used 
for suture threads, orthopedic screws, and prostheses manufacture since 1970, 
and more recently, they have been evaluated for scaffold production and tissue 
engineering strategies. About this, Eğri et al. combined PLA and PGA to obtain a 
PLA-PEG-PLA scaffolds able to release VEGF and BMP-2 in bone tissue lesion. In 
relation to its chemical composition, the scaffold allows fast release of VEGF in 
about 1 week and slower constant release of BMP-2 [35].
4.3 Metals
Metals are particularly suitable for tissue engineering strategies for their good 
mechanical properties such as high elastic module, yield strength, and high ductil-
ity allowing them to bear a load without being deformed. If mechanical resistance 
makes them excellent candidates for scaffold production, however, the reduced 
cell adhesion to their surface could be a considerable limit to their use. Moreover, 
metal implants can release toxic metallic ions and/or particles, and biological fluids 
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can show corrosive action on their surface that can alter their function. Among the 
different metals used for scaffold production, there are stainless steel, cobalt, and 
titanium alloys.
Stainless steels are iron-based alloys with a low content of carbon and a high 
content of chromium. The presence of carbon ensures good mechanical properties 
but determines carbides formation that makes the scaffold subject to corrosion in a 
biological environment.
Cobalt-based alloys are of two types: cobalt/chromium/molybdenum alloy 
obtained with casting/melting methods and cobalt/nickel/chromium/molybdenum 
alloy worked by forging. Generally, the high level of chromium and molybdenum 
typical of these alloys increase granule size and improve mechanical properties.
Titanium alloys can be alpha, beta or alpha/beta biphasic. Alpha alloys contain 
alpha stabilizers such as aluminum and gallium and are characterized by good 
strength, hardness, resistance sliding, and weld ability; Beta alloys contain beta 
stabilizers such as vanadium, niobium, and tantalus molybdenum and show good 
ductility. Alpha/beta biphasic alloys show a mix of alpha/beta stabilizers, and they 
are quite ductile even if little resistant to high temperatures, and the most suitable 
one for biomedical application is Ti 6Al 4 V.
Wohlfahrt et al. tested the osteoinductivity and osteointegration capabilities of 
Ti and TiO2 scaffolds in rabbit tibia peri-implant osseous defects. After 4 weeks, the 
implant was removed and the new bone formation was observed. Moreover, a gene 
expression analysis was performed considering different osteogenesis differentia-
tion markers such as osteocalcin and collagen-I [36].
In another study, Zuchuat et al. developed Cr-Co-Mo membranes and placed 
them in rabbit tibiae to analyze the volume of new bone formation. After the 
explant, histological analysis showed a huge number of osteoblasts and osteocytes 
on the scaffold [37].
4.4 Composites
Composite scaffolds are developed combining different biomaterials such as 
natural or synthetic polymers (PGA, PLA, gelatin, chitin, and chitosan), ceramics 
(hydroxyapatite and beta-tricalcium phosphate or bioglasses), and metals. They 
have technological, industrial, and applicative importance since they combine 
biocompatibility, biodegradation, and appreciable mechanical strength. Moreover, 
these kinds of scaffolds could be applied for both hard and soft tissue regeneration 
and greatly mimic tissue architecture being composed of cells and extracellular 
matrix.
Several studies displayed the efficacy of composite scaffolds (polymers/ceramics 
and synthetic/natural polymers) for tissue engineering strategies [38, 39].
Other researchers demonstrated that another interesting solution may be the 
combination of metallic implants with polymer coating or metal/ceramic scaffolds 
[40, 41].
4.5 Hydrogels
Hydrogels are hydrophilic polymers rich of polar moieties such as carboxyl, 
amide, amino, and hydroxyl groups, held together by chemical bounds or physical 
intra-molecular and inter-molecular attractions. Their main feature is the abil-
ity to absorb enormous amounts of water or biological fluids and swell without 
dissolving.
According to their origin, hydrogel can be classified into natural (made of poly-
peptides and polysaccharides), synthetic (obtained by traditional polymerization), 
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and semi-synthetic. Moreover, they can present an amorphous or semi-crystalline 
structure that can be cationic, anionic, neutral, or ampholytic. Depending on their 
stability in a biological system, they can be considered durable if they do not undergo 
chemical-physical modification or biodegradable if they degrade into oligomers, 
which are subsequently eliminated from the body. In the last decades, smart hydro-
gels have been developed featured by the possibility to modify their structure and 
mechanical properties according to environmental stimuli such as pH or tempera-
ture. Already 50 years ago, these materials have been appreciated for their chemical-
physical characteristics by Wichterle and Lim, who developed a poly(2-hydroxyethyl 
methacrylate)-based hydrogel for contact lens [42]. Since they present a soft and 
rubbery consistency very similar to that of ECM of different tissues, they have been 
recently studied for tissue engineering strategies. In particular, hydrogels used for 
scaffold production may respond to important requirements such as biocompatibility 
and controlled in vivo biodegradation. It is very important to modulate parameters 
such as hydrogel cross-linking density, porosity, pore size, and interconnectivity to 
obtain a suitable structural for cellular colonization and proliferation. Hydrogels 
can be modified at the surface by peptides or growth factor, which can promote cell 
attachment and differentiation process. Generally, natural hydrogels are less toxic 
Table 1. 
Advantages, disadvantages, and main clinical uses of different kinds of biomaterials.
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and more tolerated than synthetic ones, and Pasqui et al, for example, developed a 
natural cellulose-hydroxyapatite hybrid hydrogel for bone tissue engineering. For the 
chemical synthesis procedure, the freeze-dried hydrogel was immersed in a solution 
containing HA microcrystals, and then an in vitro study demonstrated that MG63 
osteoblast-like human cell seeded into hydrogel samples adhered and proliferated 
rapidly. Moreover, an increase of ALP activity was identified at 3, 7, and 14 days 
[43]. Synthetic hydrogels could have limitations in the biocompatibility, but they 
offer the possibility to modulate their mechanical features and rate of degradation in 
biological environment. Kinard et al. developed a biodegradable oligo[poly(ethylene 
glycol)fumarate] hydrogel to deliver demineralized bone matrix (DBM) in a rat bone 
defect. They found that the in vivo degradation rate of the hydrogel depend on the 
DBM content, higher was the rate of DBM faster was the degradation. Moreover, 
high content of DBM could affect the mechanical properties of the hydrogel even if it 
increases its osteoinductivity in vitro and in vivo [44] (Table 1).
5. Processing techniques for scaffold production
After the choice of the biomaterial to use for scaffold production, it is quite 
important to select an adequate processing technique that allows to maintain high 
levels of control of the macro- and micro-structural properties of the same. The 
processing methodology must satisfy key requirements such as: process accuracy 
and repeatability. The scaffolds obtained will present regular shaped pores with 
consistent pore size and interconnectivity and should not show any physical-
chemical variations when produced by the same method. Moreover, the processing 
conditions must not alter the mechanical properties of the biomaterial, and any 
toxic solvent used during the process must be totally removed not to limit scaffold 
clinical use [3, 11]. Among the most spread processing techniques, probably the 
most known are those that foresee the employment of a porogenous organic or inor-
ganic agent such as sodium chloride, sodium tartrate, sodium citrate, citric acid, or 
saccharose. However, the use of porogens limits the scaffolds to thin membranes 
with a thickness of 2 mm to facilitate complete porogen removal [45].
Mikos et al. described solvent casting/particulate leaching for the first time, and 
it is chosen for the fabrication of porous scaffold used for bone tissue engineering. 
In this case, the porous agent is dispersed in appropriate solvent and then the dis-
persion is processed by casting or by freeze-drying. This technique allows obtaining 
thin membranes with 30–300 micrometer pore size and 20–50% porosity even if 
the pores have a shifting shape and the interconnectivity is quite low. However, the 
method presents some disadvantages like time consuming (it is necessary to wait for 
days or weeks for solvent evaporation) and the use of toxic organic solvents [46].
In melt molding/particulate leaching, an unrefined thermoplastic polymer 
is mixed with the porous agent and then the blend is poured in a mold with an 
appropriate shape. The mold is then heated above the glass transition temperature 
of the polymer and at last the obtained solid is immersed in a solvent to promote the 
dissolution of the porogens. The advantage of this methodology is the possibility to 
monitor the pore size and porosity (generally 80–84%) by varying the amount of 
porogenous [47]. A good variant of melt molding is extrusion or injection mold-
ing proposed by Gomes et al., who replaced the porous agent with a blowing agent 
based on citric acid. During the heating process, the blowing agent degraded pro-
ducing carbon dioxide which formed interconnected and well-shaped pores [48].
Gas foaming is an high pressure processing technique described by Mooney 
et al who produced sponges of poly(D,L-lactic-co-glycolic acid) without the use 
of organic solvents. Solid disks of the polymer are exposed to high pressure CO2 
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(5.5 MPa) at room temperature followed by a decreasing of gas pressure to reduce 
its solubility in the polymer bulk. It brings CO2 to abandon the polymer forming 
well-shaped pores [49].
Phase inversion/particulate leaching is a valid method to obtain polymeric scaf-
folds. After the polymer solubilization in a suitable solvent, the solution is dissolved 
in water that provokes the polymer precipitation. Obviously, it is possible to modu-
late the characteristics of the scaffolds obtained through this method by varying 
the polymer concentration but also the temperature of the solution. Holy et al. used 
this technique to develop porous PLGA scaffold with architecture similar to osseous 
trabecular for bone tissue engineering [50].
Another interesting method is the fiber bonding. It allows obtaining scaffolds 
containing a dense frame of synthetic fibers that form a sufficiently porous three-
dimensional structure. This technique provides the alignment of the PGA fibers in 
the desired orientation and subsequently they are covered with a PLLA/methylene 
chloride solution and heated above the melting temperatures of both polymers. 
When PLLA is removed through a dissolution process, the PGA fibers remain 
attached to each other forming a thick net.
In the freeze-drying method, the polymer solution is first frozen rapidly at tem-
peratures below 0°C followed by solvent removal by vacuum sublimation. It can be 
applied to obtain both natural and synthetic scaffolds [51]. At last, the progress of 
computer technology led to the development of new techniques like solid freeform 
fabrication (SSF) whose introduction has signed a new era for manufacturing 
industry. These techniques allow to produce layer-by-layer 3D objects starting 
from information generated by CAD system or computer-based medical imaging 
modalities. Obviously, the use of a computerized production system saves time 
and modulates with extreme precision parameters related to the micro and macro 
architecture of the scaffold.
The first SFF technique used for tissue engineering purpose was 3D printing. This 
technique uses a printer head that places a liquid binder onto thin layers of powder 
following the object shape generated by a CAD system. Using this technique, Kim  
et al. obtained porous PLGA scaffolds [52], while Zeltinger et al. created poly(l-lactic 
acid) disk shaped scaffolds with two different porosities (75% and 90%) and four 
different pore size distributions (<38, 38–63, 63–106, and 106–150 μm) [53].
Another interesting SFF methodology is fused deposition modeling (FDM). In this 
case, a filament of thermoplastic material is fed and melted inside a heated liquifier 
head and then it is forced out by an extruder and deposited on a platform. Layer by 
layer, the 3D object is then obtained. By varying the direction of material deposition 
for each layer, it is possible to change the pore size and interconnectivity of the scaf-
fold. Using this methodology, Hutmacher et al. obtained polycaprolactone scaffolds 
with honeycomb-like structure and a porosity of 61 +/− 1% and proved their in vitro 
ability to promote proliferation of primary human fibroblasts and periosteal cells [54].
6.  Biomaterials for bone tissue engineering: current applications and 
new perspectives
One of the current problems in orthopedic clinic is represented by bone lesions 
caused by traumas, cancer resection degenerative diseases, or nonunion of frac-
tures, which do not heal spontaneously but require surgical procedures. Today, the 
gold standard for osseous replacement is the autologous bone graft. This technique 
employs cells of the same patient generally taken from different sites such as 
fibula or iliac crest that are implanted in bone defect to promote a rapid healing. 
Although it minimizes the risk of autoimmune response, which was the critical side 
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of xenogenic grafts, it presents some disadvantages such as donor site morbidity, 
infections, and post-surgery chronic pain [55–57]. In sight of this, science aims to 
find innovative solutions like application of biomaterials to orthopedics in order to 
develop medical implant useful to accelerate the healing, restoring the physiological 
functions of bone.
The design of an implant for skeletal defects may consider the main character-
istics of bone tissue which is divided into two different forms: cortical bone, almost 
solid with less than 10% porosity and trabecular bone organized in a sponge-like 
pattern with a porosity of 50–60% [58]. According to the classification of Hanch 
and Navarro, the evolution of bone implant devices has marked three different 
generations: (a) bio-inert materials (first generation), (b) bioactive and biode-
gradable materials (second generation), and (c) biomaterials capable of inducing 
specific cellular responses by incorporating into a 3D scaffold bone progenitor cells 
and growth factors [59, 60].
The purpose of first generation of implants was the integration with host 
tissue without eliciting specific immune response. These implants include metals 
(Stainless steel, Ti-based, and Co–Cr-based alloys), ceramics (natural and synthetic 
HA), and polymers (silicone rubber, PE, acrylic resins, polyurethanes, polypropyl-
ene PP, and polymethylmethacrylate).
The second generation of implants was developed between 1980 and 2000 and 
intends to improve both the bioactivity and in vivo biodegradation. To this purpose, 
one of the possible strategies was to modify the first generation by strategic coat-
ing such as HA, beta-tricalcium phosphate (b-TCP), or bioactive glass. Another 
innovation was the use of natural or synthetic polymers like, poly(p-caprolactone), 
polylactide, polyglicolide, and chitosan with controlled in vivo biodegradation rate.
Third generation of implants combines biomaterials useful to develop 3D porous 
bioactive, biodegradable scaffolds with the integration of progenitor cells, and 
specific growth factors. This innovation laid the foundations for modern bone tissue 
engineering strategies. Even if an ideal combination of biomaterials for scaffold 
production has not been identified yet, recent studies have demonstrated the great 
efficiency of ceramics in mimic chemical-physic characteristics of bone tissue 
ECM. Also, our group tested in vitro and in vivo potential of collagen type-1/Ha-Mg 
combination to promote bone injury healing. We demonstrated that although 
biomimetic scaffolds are “per sè” able to promote tissue regeneration thanks to their 
high osteoinductivity, their combination with progenitor cells and growth factors 
would be more efficient [19–21]. Generally, osteogenic cells such as adult stem cells 
(ASC) isolated from adult tissues like bone marrow, adipose tissue, or muscle are 
good candidate to be transplanted in skeletal lesion together with an appropriate 
scaffold. These kinds of cells are characterized by high capacity of self-renewal and 
potential of osteogenic differentiation. Moreover, it has been suggested that ASC 
possess immunosuppressive effects, which make them particularly privileged for 
transplantation in vivo.
Growth factors are cytokines normally secreted by different cell types. Acting 
on their own receptors, they induce intracellular pathways, which promote 
proliferation, cellular adhesion, and differentiation. Bone tissue produces differ-
ent growth factors such as bone morphogenetic proteins (BMPs), transforming 
growth factor beta (TGFb), fibroblast growth factors (FGFs), insulin growth 
factor I and II (IGF I/II), and platelet-derived growth factor (PDGF), which 
have been proposed for tissue engineering strategies. In particular, BMP2 and 7 
have been cloned and are commercially available as recombinant proteins. The 
interest in them for bone regenerative practices has increased since 1965 when 
Urist discovered that demineralized bone transplanted in subcutaneous tissue 
induces bone formation [61]. This potential was later attributed to the presence of 
Biomaterial-supported Tissue Reconstruction or Regeneration
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BMP. Obviously, the choice to include a growth factor in the scaffold requires the 
use of biomaterials that can act as drug delivery systems protecting the cytokine 
from in vivo proteolysis and ensuring a progressive and controlled release over 
time. In this sense, a good alternative is the physical immobilization of the growth 
factor in a biodegradable hydrogel. In this case, the release will be controlled by 
the in vivo degradation of hydrogel cross-linked with generation of water-soluble 
hydrogel fragments [9] (Figure 1).
7. Conclusions
Recently, the interest in natural and synthetic biomaterials for medical devices 
production has increased, and more and more in-depth studies are carried out to better 
detect their possible applications linked to chemical-physical features and the extrac-
tive or synthetic methods, which do not alter their structural properties and biocom-
patibility. Moreover since tissue engineering strategies have become a valid alternative 
for body structure and function restoring, biomaterials are also used for the fabrication 
of 3D porous biomimetic bioactive scaffolds with controlled degradation rate in vivo.
As previously mentioned, the main classes of biomaterials for scaffold production 
are ceramics, natural and synthetic polymers, metals, composites, and hydrogels. In 
vitro and in vivo studies have showed the advantages related to their use in regenera-
tive medicine field but they have also highlighted the possible negative sides.
Regarding the application of biomaterials to tissue engineering, the current aim 
of science is to find the natural or synthetic substance or the combination with the 
most satisfactory performance in vivo, able to promote cell proliferation and dif-
ferentiation in a tissue lesion in order to restore the normal architecture of ECM.
In conclusion, tissue engineering strategies especially in orthopedic clinic field 
represent an effective and sophisticated alternative for the future, but their suc-
cess strictly depends on an ever deeper knowledge about the characteristics of the 
biomaterials and the potentialities of their combinations.
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